Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of FTB-8127 in patients with post-herpetic neuralgia
jRCT2080220444Phase 3Completed
- Sponsor
- Fuso Pharmaceutical Industries
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing FTB-8127 with Placebo (2 arms). Started Sep 2007; status: completed.
02
Drugs
mirogabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2080220444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220444.